Classer les publications sur l'année
-
Économie de la santé
Perioperative time and economic impact of an intracameral combination of mydriatics and anaesthetics in routine cataract surgery.
ZALUSKI S, AMZALLAG T, BOUCHUT P, PINSARD L, THERON JP, TELLOUCK-MORINCOMME J, BAFFERT S.
Eur J Ophthalmol ; 2023;33(1):239-246
-
Économie de la santé
Modelling lifetime cost consequences of toric compared with standard IOLs in cataract surgery of astigmatic patients in four European countries
LAURENDEAU C, LAFUMA A, BERDEAUX G
J Med Economics ; 12(3):230-237
-
Économie de la santé
Modelling the lifetime economic consequences of glaucoma in France
PHILIPPE NORDMANN J, LAFUMA A, BERDEAUX G
J Med Econ ; 12(1):9-16
-
Économie de la santé
Modelling lifetimes cost consequences of RESTOR for presbyopia in four European countries
LAFUMA A, BERDEAUX G
Eye ; 23(5):1072-80
-
Pharmaco-Epidémiologie
Les troubles musculosquelettiques en viticulture : prévalence et associations avec le travail de la vigne et les facteurs psychosociaux au travail
BERNARD C, BOUÉE S, COUROUVE L, ADJEMIAN A, CHRETIEN JC, NIEDHAMMER I
Arch Mal Prof Environ ; 70:539-549
-
Pharmaco-Epidémiologie
Incidence of Nd : YAG laser capsulotomies after cataract surgery : comparison of 3 square-edged lenses of different composition
BOUREAU C, LAFUMA A, JEANBAT V, BERDEAUX G, SMITH ANDREW F
Can J Ophtalmol ; 44(2):165-170
-
Économie de la santé
Economics and attitudes regarding spectacles in daily life : a European perspective
Economics and attitudes regarding spectacles in daily life : a European perspective
Ophthalmic Epidemiol ; 16(4):218-223
-
Économie de la santé
Cost of cataract surgery after implantation of three intraocular lenses
BOUREAU C, LAFUMA A, JEANBAT V, SMITH AF, BERDEAUX G
Clin Ophtalmol ; 3:277-285
-
Économie de la santé
Cost effectiveness of Travoprost versus a Fixed Combination of Latanoprost/Timolol in Patients with Ocular Hypertension or Glaucoma : Analysis Based on the UK General Practitioner Research DataBase
DE NATALE R, LAFUMA A, BERDEAUX G
Clin Drug Investig ; 29(2):111-120
-
Économie de la santé
Modelling lifetimes cost consequences of RESTOR in cataract surgery in four European countries
LAFUMA A, BERDEAUX G
BMC Ophtalmol ; 8(1):12
-
Pharmaco-Epidémiologie
Intraocular pressure control with latanoprost/timolol and travoprost/timolol fixed combinations : a retrospective, multicentre, cross-sectional study
DENIS P, LAFUMA A, JEANBAT V, LAURENDEAU C, BERDEAUX G
Clin Drug Investig ; 28(12):767-776
-
Pharmaco-Epidémiologie
Intermediate visual acuity without spectacles following bilateral ReSTOR® implantation
CUQ C, SPERA C, LAURENDEAU C, LAFUMA A, BERDEAUX G
Eur J Ophtalmol ; 18(5):733-738
-
Économie de la santé
Costs and persistence of carbonic anhydrase inhibitor versus alpha2 agonists, associated with beta-blockers, in glaucoma an ocular hypertension : an analysis of the UKGPRD database
LAFUMA A, BERDEAUX G
Curr Med Res Opin ; 24(5):1519-1527
-
Économie de la santé
Costs and persistence of brimonidine versus brinzolamide in everyday glaucoma care : an analysis conducted on the UK General Practitioner Research Database
LAFUMA A, LAURENDEAU C, BERDEAUX G
J Med Econ ; 11(3):485-497
-
Économie de la santé
Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by the United Kingdom General Practitioner Research Database
DENIS P, LAFUMA A, BERDEAUX G
Clin Ophtalmol ; 2(2):321-329